SFX by Ex Libris Inc.

Title:	BRCA1 is secreted and exhibits properties of a granin
Source:	Nature Genetics [1061-4036] Jensen, Roy yr:1996

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Gawenda, J. "Legumain expression as a prognostic factor in breast cancer patients." Breast Cancer Research and Treatment 102.1 (2007): 1-6.
description	2.	Liu, C. "Overexpression of Legumain in Tumors Is Significant for Invasion/Metastasis and a Candidate Enzymatic Target for Prodrug Therapy." Cancer research 63.11 (2003): 2957-2964.
description	3.	Morita, Y. "Legumain/asparaginyl endopeptidase controls extracellular matrix remodeling through the degradation of fibronectin in mouse renal proximal tubular cells." FEBS letters 581.7 (2007): 1417-24.
description	4.	Rotari, V I I. "Legumain forms from plants and animals differ in their specificity." Biological chemistry 382.6 (2001): 953-9.
description	5.	Luo, Y. "Targeting tumor-associated macrophages as a novel strategy against breast cancer." The journal of clinical investigation 116.8 (2006): 2132-2141.
description	6.	Lam, E. "Vacuolar proteases livening up programmed cell death." Trends in cell biology 15.3 (2005): 124-127.
description	7.	Liu, Y. "Targeting Cell Surface Alpha(v)beta(3) Integrin Increases Therapeutic Efficacies of a Legumain Protease-Activated Auristatin Prodrug." Molecular pharmaceutics 9.1 (2012): 168-75.
description	8.	Choi, Sun J. "Osteoclast inhibitory peptide 2 inhibits osteoclast formation via its C-terminal fragment." Journal of bone and mineral research 16.10 (2001): 1804-11.
description	9.	Burris, Howard A. "Phase II Study of the Antibody Drug Conjugate Trastuzumab-DM1 for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2) -Positive Breast Cancer After Prior HER2-Directed Therapy." Journal of clinical oncology 29.4 (2010): 398-405.
description	10.	Chen, J.-M. M. "Identification of the active site of legumain links it to caspases, clostripain and gingipains in a new clan of cysteine endopeptidases." FEBS letters 441.3 (1998): 361-365.
description	11.	Isidro-Llobet, A. "Amino Acid-Protecting Groups." Chemical reviews 109.6 (2009): 2455-2504.
description	12.	Tang, T. "Testisin, a glycosyl-phosphatidylinositol-linked serine protease, promotes malignant transformation in vitro and in vivo." Cancer research 65.3 (2005): 868-78.
description	13.	Kinoshita, T. "Homologues of a vacuolar processing enzyme that are expressed in different organs in Arabidopsis thaliana." Plant molecular biology 29.1 (1995): 81-89.
description	14.	Papaspyridonos, M. "Novel candidate genes in unstable areas of human atherosclerotic plaques." Arteriosclerosis, thrombosis, and vascular biology 26.8 (2006): 1837-44.
description	15.	Vigneswaran, N. "Silencing of cystatin M in metastatic oral cancer cell line MDA-686Ln by siRNA increases cysteine proteinases and legumain activities, cell proliferation and in vitro invasion." Life Sciences 78.8 (2006): 898-907.
description	16.	Reeck G R, T H H. ""Homology" in proteins and nucleic acids: a terminology muddle and a way out of it." Cell 50.5 (1987): 667-667.
description	17.	Rosin, F. "Moonlighting vacuolar protease: multiple jobs for a busy protein." Trends in plant science 10.11 (2005): 516-518.
description	18.	Chen, J.-M. M. "Cloning, isolation, and characterization of mammalian legumain, an asparaginyl endopeptidase." The Journal of biological chemistry 272.12 (1997): 8090-8098.
description	19.	Loak, K. "Novel cell-permeable acyloxymethylketone inhibitors of asparaginyl endopeptidase." Biological Chemistry 384.8 (2003): 1239-46.
description	20.	Schwarz, G. "Characterization of legumain." Biological chemistry 383.11 (2002): 1813-1816.